BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2295693)

  • 1. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients.
    Klein BS; Jones JM
    J Clin Invest; 1990 Jan; 85(1):152-61. PubMed ID: 2295693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis.
    Klein BS; Hogan LH; Jones JM
    J Clin Invest; 1993 Jul; 92(1):330-7. PubMed ID: 8326001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine antibody response to Blastomyces dermatitidis WI-1 antigen.
    Klein BS; Squires RA; Lloyd JK; Ruge DR; Legendre AM
    Am J Vet Res; 2000 May; 61(5):554-8. PubMed ID: 10803652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Western immunoblot analysis and serologic characterization of Blastomyces dermatitidis yeast form extracellular antigens.
    Hurst SF; Kaufman L
    J Clin Microbiol; 1992 Dec; 30(12):3043-9. PubMed ID: 1452683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis.
    Klein BS; Sondel PM; Jones JM
    Infect Immun; 1992 Oct; 60(10):4291-300. PubMed ID: 1383148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen.
    Klein BS; Jones JM
    Infect Immun; 1994 Sep; 62(9):3890-900. PubMed ID: 7520423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents.
    Soufleris AJ; Klein BS; Courtney BT; Proctor ME; Jones JM
    Clin Infect Dis; 1994 Jul; 19(1):87-92. PubMed ID: 7948563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a purified skin test antigen from Blastomyces dermatitidis yeast-phase cell wall.
    Lancaster MV; Sprouse RF
    Infect Immun; 1976 Sep; 14(3):623-5. PubMed ID: 965086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay: a sensitive screening test for histoplasmosis and blastomycosis.
    George RB; Lambert RS; Bruce MJ; Pickering JW; Wolcott RM
    Am Rev Respir Dis; 1981 Oct; 124(4):407-10. PubMed ID: 7294503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.
    Wüthrich M; Chang WL; Klein BS
    Infect Immun; 1998 Nov; 66(11):5443-9. PubMed ID: 9784555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification in quantity of the secreted form of WI-1: a major adhesin on Blastomyces dermatitidis yeasts.
    Audet R; Brandhorst TT; Klein B
    Protein Expr Purif; 1997 Nov; 11(2):219-26. PubMed ID: 9367819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and ELISA evaluation of Blastomyces dermatitidis yeast phase lysate antigens.
    Johnson SM; Scalarone GM
    Diagn Microbiol Infect Dis; 1988 Oct; 11(2):81-6. PubMed ID: 3229098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies and delayed hypersensitivity with Rotofor preparative IEF fractions of Blastomyces dermatitidis yeast phase lysate antigen.
    Bono JL; Legendre AM; Scalarone GM
    J Med Vet Mycol; 1995; 33(4):209-14. PubMed ID: 8531017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastomyces dermatitidis Antibody and Antigen Detection: Comparison of Four Lysate Antigens and Antibodies Prepared from Human Isolates from a Blastomycosis Outbreak.
    Hammon JT; Kennell BC; Scalarone GM
    Mycopathologia; 2019 Oct; 184(5):661-666. PubMed ID: 31583528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.
    Bariola JR; Hage CA; Durkin M; Bensadoun E; Gubbins PO; Wheat LJ; Bradsher RW
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):187-91. PubMed ID: 21251563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis.
    Wüthrich M; Klein BS
    J Infect Dis; 2000 May; 181(5):1720-8. PubMed ID: 10823774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of histoplasmosis and blastomycosis by an antiglobulin hemagglutination test.
    Khansari N; Segre D; Segre M
    Am J Vet Res; 1982 Dec; 43(12):2279-83. PubMed ID: 6819794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources.
    Abuodeh RO; Chester EM; Scalarone GM
    Mycoses; 2004 Apr; 47(3-4):143-9. PubMed ID: 15078431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and chemical characterization of glycoproteins in IEF fractions of Blastomyces dermatitidis yeast lysate antigen.
    Fisher MA; Legendre AM; Scalarone GM
    Mycoses; 1997 Sep; 40(3-4):83-90. PubMed ID: 9375492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibody responses and delayed dermal hypersensitivity with Blastomyces dermatitidis yeast and mycelial lysate antigens.
    Seawell BW; Wheeler JY; Yearsley K; Alexander KL; Legendre AM; Scalarone GM
    Mycopathologia; 1991 Jun; 114(3):137-44. PubMed ID: 1886639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.